Merck KGaA debut Euro Benchmark Bond launched

13 August 2006

Darmstadt, Germany-headquartered Merck KGaA says it has successfully launched its debut Euro Benchmark Bond in the European debt capital market. The issue has a size of 500.0 million euros ($643.3 million) and a maturity of seven years. The bond pays a coupon of 3.75% and was issued at a price of 99.716%. This corresponds to a spread of 47 basis points over mid-swaps. The bond will be listed on the Luxembourg Stock Exchange.

Proceeds of the transaction will be used for general corporate purposes and the issue will replace expiring bilateral credit lines provided to date by banks. In addition, it will improve the maturity structure of finance commitments. At the same time, Merck used the current favorable market conditions to attract new investors, the firm said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight